Infection and xenotransplantation developing strategies to minimize risk

Annals of the New York Academy of Sciences

Volumn 862, Issue , 1998, Pages 52-66

  Fishman, Jay A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; CONFERENCE PAPER; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROBIOLOGY; RISK MANAGEMENT; XENOGRAFT; XENOTRANSPLANTATION;

EID: 0032430792     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09117.x     Document Type: Conference Paper

References (63)

1. 16. Fishman, J.A. & R.H. Rubin. 1998. Infection in the organ transplant patient. N. Engl. J. Med. 338: 1741-1751.
2. 17. Fishman, J.A. 1997. Xenosis and xenotransplantation: Addressing the infectious risks posed by an emerging technology. Kidney International 51:(Suppl. 58) 41-45.
3. 18. Fishman, J.A. 1994. Miniature swine as organ donors for man: Strategies for prevention of xenotransplant-associated infections. Xenotransplantation 1: 47-57.
4. 19. Michaels, M.G. & R.L. Simmons. 1994. Xenotransplant-associated zoonoses: Strategies for prevention. Transplantation 57: 1-7.
5. 20. Institute of Medicine. 1992. Emerging Infections: Microbial threats to health in the United States. National Academy Press. Washington, DC.
6. 21. Cooper, D.K.C., R.P. Lanza, S. Oliver, et al. 1983. Infectious complications after heart transplantation. Thorax 38: 822-828.
7. 22. Katz, R.A. & A.M. Skalka. 1990. Generation of diversity in retroviruses. Annu. Rev. Genet. 24: 409-405.
8. 23. Javier, R.T., F. Sedarati & J.G. Stevens. 1986. Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science 234: 746-748.
9. 24. Isfort, R., D. Jones, R. Kost, Witter & H. Kung. 1992. Retrovirus insertion into herpesvirus in vitro and in vivo. Proc. Natl. Acad. Sci.89: 991-995.
10. 25. Rando, R.F., A. Srinivasan, J. Feingold, E. Gonczol & S. Plotkin. 1990. Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology 176:87-97.
11. 26. Stoye, J.P. & J.M. Coffin. 1985. Endogenous viruses. In RNA Tumor Viruses. R. Weiss, N. Teich, H. Varmus & J. Coffin, Eds. :357. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY.
12. 27. Temin, H.M. 1985. Reverse transcription in the eukaryotic genome, retroviruses, pararetroviruses, retrotransposons, and retrotranscripts. Mol. Biol. Evol. 6: 455-468.
13. 28. Relman, D.A. 1993. The identification of uncultured microbial pathogens. J. Infect. Dis. 168: 1-8.
14. 29. Wilson, M.E. 1995. Travel and the emergence of infectious diseases. Emerging Infectious Diseases 1: 39-46.
15. 30. Woese , C.R. 1987. Bacterial evolution. Microbiol. Rev. 51: 221-271.
16. 31. Gloster, J., R.F. Sellers & A.I. Donaldson. 1982. Long distance transport of foot-and-mouth disease virus over sea. Vet. Rec. 100: 47-52.
17. 32. Christensen, L.S., K.J. Sorensen, B.S. Strandby-Gaard, C.A. Henrikson & J.B. Anderson. 1990. Evidence of long distance airborne transmission of Aujeszky's disease virus-1. Identification of emerging strains. Proceedings of the 11th International Congress of the Pig Veterinary Society : 206.
18. 33. Trexler, P.C. & L.I. Reynolds. 1957. Flexible film apparatus for the rearing and use of germ-free animals. Appl. Microbiol. 5: 406-412.
19. 34. Gloster, J., R.M. Blackall, R.F. Sellers & A.I. Donaldson. 1981. Forecasting the airborne spread of foot-and-mouth disease. Vet. Rec. 1981 108: 376.
20. 35. Goodwin, R.F.R., R.F. Sellers & J. Gloster. 1980. The phenomenon of suppressed respiratory disease in litters of older sows: The Nothumberland epidemic of foot-and-mouth disease. Vet. Rec. 85: 129-140.
21. 36. Underdahl, N.R., L.C. Welch & G.A. Young. 1963. Evaluation of problems related to introduction of secondary specific pathogen-free (SPF) boars into SPF and non-SPF herds. J. Am. Vet. Med. Assoc. 142: 634-638.
22. 37. Caldwell, J.D., L.J. Sumption & G.A. Young. 1959. Swine repopulation. II. Performance of "disease-free" boars on farms with diseased pigs. J. Am. Vet. Med. Assoc. 135: 504-505.
23. 38. Edington, N., A.E. Wrathall & J.T. Done. 1988. Porcine cytomegalovirus (PCMV) in early gestation. Vet. Microbiol. 17: 117-128.
24. 39. Kohler, W., H. Queisser, E. Kunter, R. Sawitzki & G Frach. 1989. Type 2 streptococcus suis (R-Streptococci) as pathogens of occupational diseases. Report of a case and a review of the literature. Z. Gesamte Inn. Med. Grenzge. 44: 144-148.
25. 40. Kaufhold, A., R. Lutticken & S. Litterscheid. 1988. Systemic infection caused by streptococcus suis. Dtsch. Med. Wochenschr. 113: 1642-1643.
26. 41. Starzl, T.E., J. Fung & A. Tzakis, et al. 1993. Baboon to human liver transplantation. Lancet 341: 65-71.
27. 42. Starzl, T.E., A. Tzakis, J.J. Fung, S. Todo, A.J. Demetris, R. Manez, et al. 1994. Prospects of clinical xenotransplantation. Transplant. Proc. 26: 1082-1088.
28. 43. Sharrow, S.O., J.S. Arn, I. Stroynowski, L. Hood & D.H. Sachs. 1989. Epitope clusters of Qa-2 antigens defined by a panel of new monoclonal antibodies. J Immunol. 142: 3495-3502.
29. 44. van Goor, H., C. Rosman, J. Grond, et al. 1994. Translocation of bacteria and endotoxin in organ donors. Arch. Surg. 129: 1063-1066.
30. 45. Papa, M., Z. Halperin, E. Rubenstein, et al. 1983. The effect of ischemia of the dog's colon on the transmural migration of bacteria and endotoxin. J. Surg. Res. 35: 264-269.
31. 46. Ho, M., G. Miller, R.W. Atchinson, et al. 1985. Epstein Barr virus infections and DNA hybridization studies in post transplantation lymphoma and lymphoproliferative lesions the role of primary infection. J. Infect. Dis. 152: 876-886.
32. 47. Cen, H., M.C. Breinig, R.W. Atchinson, M. Ho & J.L.C. McKnight. 1991. Epstein-Barr virus transmission via the donor organs in solid organ transplantation polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3 and IR4. J. Virol. 65: 976-980.
33. 48. Dummer, J.S., S. Erb, M. Breinig, et al. 1989. Infection with human immunodeficiency virus in the Pittsburgh transplant population. Transplantation 47: 134-139.
34. 49. Erice, A., F.S. Rhame, R.C. Heussner, D.L. Dunn & H.H. Balfour. 1991. Human immunodeficiency virus infection in patients with solid-organ transplants report of five cases and review. J. Rev. Infect. Dis. 13: 7-47.
35. 50. Rubin, R.H. & N.E. Tolkoff-Rubin. 1988. The problem of human immunodeficiency virus (HIV) infection and transplantation. Transplant. Immunol. 1: 36
36. 51. Dummer, J.S., J. Armstrong, J. Somers, et al. 1987. Transmission of infection with herpes simplex by renal transplantation. J. Infect. Dis. 155: 202-206.
37. 52. Pereira, B.J.G., Milford, E.L., R.L. Kirkman & A.S. Levey. 1991. Transmission of hepatitis C virus by organ transplantation. N. Engl. J. Med. 325: 454-460.
38. 53. Simmonds, R.J., D.S. Holmberg, R.L. Hurwitz, et al. 1992. Transmission of Human immunodeficiency virus type I from a seronegative organ and tissue donor. N. Engl. J. Med. 326: 726-732.
39. 54. Peterson, P.K., H.H. Balfour, S.C. Marker, D.S. Fryd, R.J. Howard & R.L. Simmons. 1980. Cytomegalovirus in renal allograft recipients. Medicine 59: 283-300.
40. 55. Settnes, O.P., V. Bille-Hansen, S.E. Jorsal & S.A. Henriksen. 1991. The piglet as a potential model of Pneumocystis carinii pneumonia. J. Protozool. 38:1405
41. 56. Chang, Y., E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
42. 57. Khabbaz, R.F., W. Heneine, J.R. George, B. Parekh, T. Rowe, T. Woods, et al. 1994. Infection of a laboratory worker with Simian Immunodeficiency Virus. N. Engl. J. Med. 330: 172-177.
43. 58. Weiss, R.A. & A.L. Wong. 1977. Phenotypic mixing between avian and mammalian RNA tumor viruses: 1. Envelope pseudotypes of Rous sarcoma virus. Virology 76: 826-834.
44. 59. Levy, J.A. 1977. Murine xenotropic type C viruses. III. Phenotypic mixing with avian leukosis and sarcoma viruses. Virology 77: 811-825.
45. 60. Lusso, P., F. Di Marzo Veronese, B. Ensoli, G. Franchini, C. Jemma, S.E. DeRocco. et al. 1990. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247: 848-852.
46. 61. Spector, D.H., E. Wade, D.A. Wright, V. Koval, C. Clark, D. Jaquish, et al. 1990. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64: 2298-2308.
47. 62. McClure, M.O., Q.J. Sattentau, P.C. Beverley et al. 1987. HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature 1330: 487-489.
48. 63. Barnett, S.W., K.K. Murthy, B.G. Herndier & J.A. Levy. 1994. An AIDS-like condition induced in baboons by HIV-2. Science 266: 642-646.
49. 64. Akioshi, D.E., M. Denaro, H. Zhu, et al. 1998. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J. Virol. : in press.
50. 65. Patience, C., Y. Takeuchi & R.A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nature Medicine 3: 276-282.
51. 66. Kaeffer, B., E. Bottreau, L.P. Thanh, M. Olivier & H. Salmon. 1990. Histocompatible miniature boar model: Selection of transformed cell lines of B and T lineages producing retrovirus. Int. J. Cancer 46: 481-488.
52. 67. McCurry, .KR., D.L. Kooyman, C.G. Alvarado, A.H. Cotterell, M.J. Martin, J.S. Logan et al. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine 1: 423-427.
53. 68. Rosengard, A.M., N.R.B. Cary, G.A. Langford, A.W. Tucker, J. Wallwork & D.J.G. White. 1995. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 59: 1325-1333.
54. 69. Rother, R.P., W.L. Fodor, J.P. Springhorn, C.W. Birks, E. Setter, M.S. Sandrin, et al. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J. Exp. Med. 182: 1345-1355.
55. 70. Welsh, R.M., F.C. Jensen, N.R. Cooper & M.B.A. Oldston. 1976. Inactivation and lysis of oncornaviruses by human serum. Virology 74:432-440.
56. 71. Welsh, R.M., N.R. Cooper, F.C. Jensen & M.B.A. Oldstone. 1975. Human serum lyses RNA tumour viruses. Nature (London) 257: 612-614.
57. 72. Galili, U., M.R. Clark, S.B. Shohet, J. Buehler & B.A. Macher. 1987. Evolutionary relationship beteen the natural anti-Gal antibody and the GalαGal epitope in primates. Proc. Natl. Acad. Sci. USA 84: 1369-1373.
58. 73. Snyder, H.W., Jr. & E. Fleissner. 1980. Specificity of human antibodies to oncovirus glycoproteins: recognition of antigen by natural antibodies directed against carbohydrate structures. Proc. Natl. Acad. Sci. USA 77: 1622-1626.
59. 74. Barbacid, M., D. Bolognesi & S.A. Aaronson. 1980. Humans have antibodies capable of recognizing oncoviral glycoproteins: Demonstration that these antibodies are formed in resonse to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc. Natl. Acad. Sci. USA 77: 1617-1621.
60. 75. Hamadeh, R.M., G.A. Jarvis, U. Galili, R.E. Mandrell, P. Zhou & J.M. Griffiss. 1992. Human natural anti-Gal IgG regulates alterantive complement pathway activation on bacterial surfaces. J. Clin. Invest. 89: 1223-1235.
61. 76. Sandrin, M.S., H.A. Vaughan & I.F.C. McKenzie. 1994. Identification of Gal(α1,3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplant. Rev. 8: 134-149.
62. 77. Sandrin, M.S., W.L. Fodor, E. Mouhtouris, N. Osman, S. Cohney, S.A. Rollins, et al. 1995. Enzymatic remodelling of the carbohydrate surface of a senogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Medicine 1: 1261-1267.
63. 78. Michaels, M.G., R. Lanford, A.J. Demetris, D. Chavez, K. Brasky, J. Fung, et al. 1996. Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation 61: 350-351.